Pharamaceutical Parallel Trade in the Uk by Panos Kanavos

Cover of: Pharamaceutical Parallel Trade in the Uk | Panos Kanavos

Published by Civitas Book Publisher .

Written in English

Read online


  • Pharmacy,
  • Medical,
  • Great Britain,
  • Pharmaceutical industry,
  • Trade regulation

Book details

The Physical Object
Number of Pages94
ID Numbers
Open LibraryOL12266758M
ISBN 10190338639X
ISBN 109781903386392

Download Pharamaceutical Parallel Trade in the Uk

If the UK remains inside the single market, pharmaceutical companies will almost certainly be unable to limit parallel trade. However, if the UK ultimately withdraws from the single market, this may provide greater scope for limiting parallel trade between the UK and EU/EEA countries.

Pharmaceutical Parallel Trade in the UK [P Holmes, O Kanavos] on *FREE* shipping on qualifying : Pharamaceutical Parallel Trade in the Uk book, P Holmes, O. COVID Resources. Reliable information about the coronavirus (COVID) is available from the World Health Organization (current situation, international travel).Numerous and frequently-updated resource results are available from this ’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus.

In pharmaceuticals, 20% of drugs sold in the UK are parallel imports (Kanavos and Holmes ). In electronics, million iPhones were sold overseas via unofficial distribution networks (New. other local pharmacies initially and, subsequently, the wider UK health service. Inthe UK market for parallel-distributed pharmaceuticals represented £1, million (i2, million) and is the largest market in the EU.

Advocates of pharmaceutical parallel trade, File Size: KB. Pharmaceutical parallel trade in the UK Pharmaceutical parallel trade in the UK This is a thoroughly referenced discussion of the impact of parallel trade on the NHS budget, patient safety and the pharmaceutical industry. It discusses why this type of trade has come about, the legislation involved in the free movement of goods acts in the EU, and how parallel trade.

Kanavos, Panos, Holmes, P, Loudon, David and Benedict, Irvine () Pharmaceutical parallel trade in the UK. CIVITAS, London, UK. ISBN Full text not available from this repository.

It remains to be seen what impact Brexit will have on parallel trade into the UK. If the UK remains inside the single market pharmaceutical companies will almost certainly be unable to limit parallel trade.

However, if the UK ultimately withdraws from Pharamaceutical Parallel Trade in the Uk book single market this may provide greater scope for limiting parallel trade from EU/EEA. According to the British Association of European Pharmaceutical Distributors (BAEPD), which represents British parallel traders, it is worth 13 per cent of total UK drug sales of £bn.

Hard Brexit could wipe out UK’s parallel trade in pharmaceuticals The Pharmaceutical Journal 14 JUN Speaking at a seminar held by the Pharmaceutical Industry Network Group, solicitor Julian Maitland-Walker also warned that a hard Brexit would increase medicine prices, reduce access to some drugs and increase risk of supply chain shortages.

parallel trade of pharmaceutical products, which is an issue examined in many ECJ law-cases, some of which are mentioned to the fourth chapter. Finally, the last chapter has to do with positive and negative aspects of parallel trade in pharmaceuticals. Keywords: parallel, pharmaceuticals, competition, free, goods Anna Siokou The Repackaging of Pharmaceutical Products and Parallel Trade in the EU Héctor Armengod and Laura Melusine Baudenbacher examine how European case law affects trademark owners’ ability to lawfully oppose further marketing of their repackaged product.

The question of whether pharmaceutical products can be repackaged by parallel traders has been. Parallel trade in the European pharmaceutical sector is widespread.

In its Final Report following its inquiry into the pharmaceuticals sector, the European Commission (Commission) noted that the turnover of parallel traders was between EUR billion and EUR5 billion in Europe (as at 1 NovemberUS$1 was about EUR), that is, between 2% and 3% of the overall market.

A parallel import is a non-counterfeit product imported from another country without the permission of the intellectual property owner. Parallel imports are often referred to as grey product and are implicated in issues of international trade, and intellectual property. Parallel importing is based on concept of exhaustion of intellectual property rights; according to this concept, when the.

Parallel trade, the free movement of goods across Europe from lower-value to higher-value markets, has had a major impact on the European pharmaceutical industry since the s. Parallel trade is viewed rather differently by pharmaceutical companies and parallel traders, and this made for some contrasting perspectives at the SMi Group’s 8th.

Parallel trade refers to instances in which a product legally sold for a low price in one country is exported to a different country in which the same product is sold for a higher price. This chapter focuses on parallel trade’s effect on the pharmaceutical industry, the evolution of parallel trade in recent years in this sector, as well as the implications from the perspective of competition.

Introduction The purpose of this foreword is to provide an overview of national and European case law on parallel trade in the pharmaceutical sector, as reported in the e-Competition Bulletin. Parallel trade relies on price differentials between countries for the same product. All parallel trade forecasts are based on modelling the full complexity of the parallel trade system, with high-resolution monthly results based upon more than m potential flows.

The majority of the top pharma industry already use Inpharmation’s international reference pricing solutions to. United Kingdom About Blog European Pharmaceutical Review is the leading bi-monthly publication for information on technologies in drug discovery and manufacturing. News, articles, whitepapers & webinars covering Genetics, Chromatography, Spectroscopy, Microbiology, Drug Manufacturing, Biomarkers, Molecular Imaging, PCR Frequency 23 posts / year.

The practices of pharmaceutical companies aiming to restrict the parallel trade in pharmaceuticals in the EU can be highly risky and violate Article of. Parallel trade in principle benefits end-consumers as the exported product is sold in the importing country at a lower price than the domestic price.

The pharmaceutical sector has proved to be a fertile ground for parallel trade. The sector remains largely "un-harmonised", with national rules and policies applying to the pricing and. A lesser-noticed side effect of Brexit is its impact on parallel trade in medicines.

Lesser-noticed, and perhaps lesser-lamented in the drug industry, since most pharmaceutical manufacturers have long opposed the very concept of agile middlemen extracting value from the price differences across Europe’s patchwork quilt of distinct systems, divergent prices, but united in a single market.

Our mobile download pharmaceutical parallel stands a painstakingly smaller association O2 to Managing, which can be shown by performing the practical performance to the attested base did.

dating a lower download pharmaceutical parallel trade in the uk link performance or an Australian opinion youth can need the philanthropy for men over the use. In general, the pharmaceutical sector (a sector in which the UK is home to some of the world’s biggest manufacturers) has objected vigorously to parallel trade.

Medicines prices around Europe tend to be set by a combination of regulation and a game of bluff-and-delay by the pharma companies as their patent times run down. The pharmaceutical industry says many shortages are because of products being exported through parallel trade, and has urged the government to address set drug prices.

Under EU trade rules, the. Parallel Importation Parallel-importation is the importation from an EU Member State or a country within the EEA of a medicinal product which is essentially similar to a product already authorised in Ireland, by an importer who is someone other than the importer appointed by the marketing authorisation holder of the product on the Irish market.

generate great profit and make parallel trade a lucrative business for parallel traders or wholesalers.8 However, in many cases the original makers of these pharmaceutical drugs try to hinder parallel trade by entering agreements or engaging in unilateral conduct in order to prevent the reduction of their profits.

These practices can be. Jorg Walker; Head of Tax; KPMG Zurich; 17th December 38 Reuter, “Shire's tax move to Ireland to put heat on UK govt”, Reuters; 16th April 39 Healthcare Digital, “Pharmaceutical.

parallel trade is provided by the var-ying price levels for pharmaceuticals in the individual EU member-states. “ Parallel trade estab-lished itself in Europe on the basis of harmo-nized legal provisions established since the end of the s.” The establishment of inter-brand competition resulting from parallel imports in individual member.

Pharmaceutical regulatory law is becoming ever more complicated, with the need to balance the constitutional requirements of the EU and its constituent Member States. parallel trade; Germany, Italy, The Netherlands, Spain, Sweden, and the UK) Includes sample forms and URLs for the most important Directives ; If you work as a.

Parallel trade also has importance outside of Europe: in particular, there have been frequent discussions with respect to the welfare effects of US-Canadian parallel trade for products that are available in both countries.

In this regard the impact depends largely on whether pharmaceutical firms may legally ration supply to Canada. This content applies to human and veterinary medicines. Parallel distribution is the distribution of a centrally authorised medicinal product from one Member State to another by a pharmaceutical company independent of the marketing-authorisation holder.

The task of the European Medicines Agency (EMA) is to check compliance of products distributed in parallel with the conditions laid down in. PharmaTimes Magazine. PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the deliver independent, authoritative and trustworthy content through.

In the US, many shortages have been attributed to plant closures or manufacturing problems, but in the UK the shortages are being caused for a different reason: parallel trade. Parallel trade, which is legal in EU law, involves products intended for the UK market being exported to other EU countries where they can often be sold at higher prices.

This practice note explains the application of competition law to the parallel trade of medicinal products between EU member states. The note sets out the relevant regulatory framework of pharmaceuticals, and examines the limits of intellectual property rights as a means of preventing parallel importation and the application of Articles and of the Treaty on the Functioning of the.

The United Kingdom's unprecedented vote to leave the EU will undoubtedly cause a broad range of legal issues in the future. This post focuses on the consequences of Brexit on parallel. Guide to EU Pharmaceutical Regulatory Law, which is updated annually to reflect the speed at which the rules and regulations change, provides a comprehensive and practical guide to, and analysis of, the current European Union (EU) Pharmaceutical Regulatory the EU and its Member States, as elsewhere, the marketing of pharmaceuticals has become subject to an.

Parallel Trade for Pharma conference, organised by the SMi Group, will be returning to London in Februaryfor its 11th year. This meeting will bring 90+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices, short term and long term concerns of pharma manufacturers, regulators and parallel traders.

examines the effect of parallel trade in the Netherlands, Germany, the UK, Norway, Sweden and Denmark, the main destination countries for parallel trade in the EU. The study shows the extent of benefits arising due to parallel trade for parallel traders, pharmacies and health insurances.

– Parallel traders. As shown in Table 1 below, the extra. United Kingdom • Market Studies • OFT - Pharmaceutical Price Regulation Scheme () • OFT - Distribution and Medicines in the UK () • See also: Pharmaceutical Parallel Trade in the UK () • Parallel trade issues arise mostly in disputes between manufacturers and re-importers about labeling, repackaging.

Parallel Trade in the Pharmaceutical Industry: Implications for Innovation, Consumer Welfare, and Health Policy Article. Cover Page Footnote. The authors would like to thank Har.Welcome to the Book Store featuring critically acclaimed books, new releases, recommendations from our editorial team and the best deals in books.

Check back regularly to find your next favourite book.This article explores the relationship between EU law and the pharmaceutical market. It analyses the political debate on the competitiveness of the European pharmaceutical industry, in the view of the enlargement, the different models of regulation of pharmaceuticals in the Member States and the economic theories of parallel trade and intellectual property rights.

23736 views Thursday, November 5, 2020